Solvias Builds HQ For Biologics And Cell And Gene Therapy Testing

Solvias, a Swiss contract research organization, is constructing a cell and gene therapy testing center in Morrisville, North Carolina. The center will be fabricated in multiple phases and is projected to employ more than 170 individuals by the end of 2025. The facility will concentrate on advanced treatments for cancer and rare diseases. Solvias currently employs 500 people at its global headquarters in Switzerland and intends to make the Morrisville facility its North American headquarters. The testing center will provide support for the characterization and release testing of cell and gene therapies as well as other advanced therapies. Keep reading to learn more about this facility and why Solvias selected North Carolina for this endeavor.